PTC Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	806.78	937.82	698.8	538.59	380.77	Upgrade
Revenue Growth (YoY)	-13.97%	34.20%	29.75%	41.45%	24.04%	Upgrade
Cost of Revenue	591.88	732.05	696.17	573.01	442.99	Upgrade
Gross Profit	214.9	205.77	2.63	-34.42	-62.22	Upgrade
Selling, General & Admin	300.91	332.54	326	285.77	244.46	Upgrade
Operating Expenses	361.65	555.18	442.55	340.52	281.36	Upgrade
Operating Income	-146.75	-349.4	-439.93	-374.94	-343.58	Upgrade
Interest Expense	-170.39	-128.88	-90.87	-86.02	-56.35	Upgrade
Currency Exchange Gain (Loss)	-	9	-31.3	-	-	Upgrade
Other Non Operating Income (Expenses)	98.12	2.81	-0.62	-45.19	51.63	Upgrade
EBT Excluding Unusual Items	-219.02	-466.48	-562.71	-506.15	-348.3	Upgrade
Merger & Restructuring Charges	-	-	-	-	-0.3	Upgrade
Gain (Loss) on Sale of Investments	11.73	-1.98	-17.29	-12.69	33.56	Upgrade
Asset Writedown	-168	-217.8	-33.38	-	-54	Upgrade
Other Unusual Items	12.18	-9.86	25.9	0.5	-33.89	Upgrade
Pretax Income	-363.12	-696.11	-587.49	-518.34	-402.93	Upgrade
Income Tax Expense	0.18	-69.51	-28.47	5.56	35.23	Upgrade
Net Income	-363.3	-626.6	-559.02	-523.9	-438.16	Upgrade
Net Income to Common	-363.3	-626.6	-559.02	-523.9	-438.16	Upgrade
Shares Outstanding (Basic)	77	75	72	70	66	Upgrade
Shares Outstanding (Diluted)	77	75	72	70	66	Upgrade
Shares Change (YoY)	2.68%	4.33%	1.79%	6.72%	12.17%	Upgrade
EPS (Basic)	-4.73	-8.37	-7.79	-7.43	-6.64	Upgrade
EPS (Diluted)	-4.73	-8.37	-7.79	-7.43	-6.64	Upgrade
Free Cash Flow	-114.19	-186.86	-388.67	-279.55	-211.91	Upgrade
Free Cash Flow Per Share	-1.49	-2.50	-5.42	-3.97	-3.21	Upgrade
Gross Margin	26.64%	21.94%	0.38%	-6.39%	-16.34%	Upgrade
Operating Margin	-18.19%	-37.26%	-62.95%	-69.62%	-90.23%	Upgrade
Profit Margin	-45.03%	-66.81%	-80.00%	-97.27%	-115.07%	Upgrade
Free Cash Flow Margin	-14.15%	-19.92%	-55.62%	-51.90%	-55.66%	Upgrade
EBITDA	-71.08	-112.81	-311.09	-310.81	-300.09	Upgrade
EBITDA Margin	-8.81%	-12.03%	-44.52%	-57.71%	-78.81%	Upgrade
D&A For EBITDA	75.66	236.59	128.84	64.13	43.49	Upgrade
EBIT	-146.75	-349.4	-439.93	-374.94	-343.58	Upgrade
EBIT Margin	-18.19%	-37.26%	-62.95%	-69.62%	-90.23%	Upgrade
Revenue as Reported	806.78	937.82	698.8	538.59	380.77	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q